Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Catalent, Inc.

CTLTNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$63.48
$0.00(0.00%)
U.S. Market opens in 17h 21m

Catalent, Inc. Fundamental Analysis

Catalent, Inc. (CTLT) shows weak financial fundamentals with a PE ratio of -11.02, profit margin of -23.81%, and ROE of -25.32%. The company generates $4.4B in annual revenue with weak year-over-year growth of 2.46%.

Key Strengths

PEG Ratio-0.19
Current Ratio2.52

Areas of Concern

ROE-25.32%
Operating Margin-17.10%
Cash Position2.52%
We analyze CTLT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -24.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-24.9/100

We analyze CTLT's fundamental strength across five key dimensions:

Efficiency Score

Weak

CTLT struggles to generate sufficient returns from assets.

ROA > 10%
-10.69%

Valuation Score

Excellent

CTLT trades at attractive valuation levels.

PE < 25
-11.02
PEG Ratio < 2
-0.19

Growth Score

Weak

CTLT faces weak or negative growth trends.

Revenue Growth > 5%
2.46%
EPS Growth > 10%
-3.50%

Financial Health Score

Moderate

CTLT shows balanced financial health with some risks.

Debt/Equity < 1
1.36
Current Ratio > 1
2.52

Profitability Score

Weak

CTLT struggles to sustain strong margins.

ROE > 15%
-2531.86%
Net Margin ≥ 15%
-23.81%
Positive Free Cash Flow
No

Key Financial Metrics

Is CTLT Expensive or Cheap?

P/E Ratio

CTLT trades at -11.02 times earnings. This suggests potential undervaluation.

-11.02

PEG Ratio

When adjusting for growth, CTLT's PEG of -0.19 indicates potential undervaluation.

-0.19

Price to Book

The market values Catalent, Inc. at 3.19 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.19

EV/EBITDA

Enterprise value stands at -24.27 times EBITDA. This is generally considered low.

-24.27

How Well Does CTLT Make Money?

Net Profit Margin

For every $100 in sales, Catalent, Inc. keeps $-23.81 as profit after all expenses.

-23.81%

Operating Margin

Core operations generate -17.10 in profit for every $100 in revenue, before interest and taxes.

-17.10%

ROE

Management delivers $-25.32 in profit for every $100 of shareholder equity.

-25.32%

ROA

Catalent, Inc. generates $-10.69 in profit for every $100 in assets, demonstrating efficient asset deployment.

-10.69%

Following the Money - Real Cash Generation

Operating Cash Flow

Catalent, Inc. generates limited operating cash flow of $268.76M, signaling weaker underlying cash strength.

$268.76M

Free Cash Flow

Catalent, Inc. generates weak or negative free cash flow of $-59.17M, restricting financial flexibility.

$-59.17M

FCF Per Share

Each share generates $-0.33 in free cash annually.

$-0.33

FCF Yield

CTLT converts -0.51% of its market value into free cash.

-0.51%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.19

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.63

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.36

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.52

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.25

vs 25 benchmark

ROA

Return on assets percentage

-0.11

vs 25 benchmark

ROCE

Return on capital employed

-0.09

vs 25 benchmark

How CTLT Stacks Against Its Sector Peers

MetricCTLT ValueSector AveragePerformance
P/E Ratio-11.0229.43 Better (Cheaper)
ROE-25.32%800.00% Weak
Net Margin-23.81%-20145.00% (disorted) Weak
Debt/Equity1.360.30 Weak (High Leverage)
Current Ratio2.524.64 Strong Liquidity
ROA-10.69%-17936.00% (disorted) Weak

CTLT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Catalent, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

38.66%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-704.95%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-13.77%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ